Acorda Therapeutics reported $18.55M in Stock for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US USD 5.84M 483K
Agios Pharmaceuticals AGIO:US USD 5.18M 1.12M
ALKERMES ALKS:US USD 166.3M 10.69M
Amgen AMGN:US USD 4.76B 203M
Anika Therapeutics ANIK:US USD 37.24M 1.9M
Biogen BIIB:US USD 1.38B 80.8M
Biomarin Pharmaceutical BMRN:US USD 839.46M 37.14M
Cara Therapeutics CARA:US USD 1.84M 1.62M
Clovis Oncology CLVS:US USD 11.42M 1.81M
Gilead Sciences GILD:US USD 2.6B 15M
GlaxoSmithKline GSK:LN GBP 4.66B 5M
Halozyme Therapeutics HALO:US USD 103.28M 5.66M
Heron Therapeutics HRTX:US USD 52.24M 9.08M
Insmed INSM:US USD 66.28M 741K
Ligand Pharmaceuticals LGND:US USD 22.33M 2.45M
Mannkind MNKD:US USD 18.27M 2.3M
Merck MRK:GR EUR 4.86B 386M
Moderna Inc MRNA:US USD 2.08B 156M
Neurocrine Biosciences NBIX:US USD 37M 7.7M
Novartis NOVN:VX USD 6.78B 101M
Teva Pharmaceutical TEVA:IT USD 3.86B 190M
Ultragenyx Pharmaceutical RARE:US USD 21.85M 770K
Vertex Pharmaceuticals VRTX:US USD 388.2M 20.5M